PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Articles

Wading through insurance industry bureaucracy is one of the most common problems faced by mental health professionals. This makes it difficult for them to collect payments on time and the impact on the collection rate eventually affects their bottom line.
Wading through insurance industry bureaucracy is one of the most common problems faced by mental health professionals. This makes it difficult for them to collect payments on time and the impact on the collection rate eventually affects their bottom line. Since Medical Billing for mental health is different compared to billing for other specialties, the process can get too overwhelming for billers who aren’t well-trained. This calls for a strong need to hire experienced professionals who are trained in handling insurance issues and can g…
Covid-19 has severely impacted the pharmaceutical industry and the supply challenges it has caused looks set to persist for the foreseeable future. Pharmaceutical companies have already experienced drug shortages, cost increases, and delivery performance degradation. In addition to this, mandates by regulatory bodies requiring jurisdictional control and in some cases the adoption of technology that does not support end-to-end supply chain collaboration has contributed to testing times.
Covid-19 has severely impacted the pharmaceutical industry and the supply challenges it has caused looks set to persist for the foreseeable future. Pharmaceutical companies have already experienced drug shortages, cost increases, and delivery performance degradation. In addition to this, mandates by regulator…
This whitepaper summarises the key elements of MHRA’s guidance document on medical devices, regarding registration, assessment procedures, labeling, post-market surveillance and vigilance that will apply for devices placed on the market in Great Britain (England, Wales and Scotland) and Northern Ireland. This document provides a list of actions that manufacturers of medical devices should take in order to continue the placement of their products on the EU and UK markets.
From January 1, 2021, the transition period after Brexit ended, and the Medicines and Healthcare products Regulatory Agency (MHRA) took on the role as the UK’s standalone medicines and medical devices regulator. On 1 September 2020, the MHRA published a set of guidance on what the rules will be from 1 January 2021. The guid…
Pharmacovigilance has developed inconceivably overall of late, and its significance when in doubt and in a general sense in the clinical thought industry has been seen. To frustrate or chop down quiet dangers, Pharmacovigilance is crucial.
Pharmacovigilance is a wide term to depict drug success. It portrays the course of action, flourishing, assessment, assumption, and checking of the malignant impacts of solutions and meds. It is a cycle driven and reliable area inside the prescription business. It is the security assessment of showed drugs separated under pragmatic or interminable states of clinical use in enormous associations. Pharmacovigilance intends to perceive dim security issues as right on time as could be viewed as average. It also plans to perceive an improvement in the rehash o…
Like never before, the superheroes in the medical profession have been applauded and profiled. In the UK, we have taken great pride in the development of treatments and vaccines, which have highlighted how the UK continues to be a great home for innovation across the life sciences spectrum. So, how does that impact the world of financial services? The short answer lies in the investment opportunities.
The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and all aspects of the healthcare system have been under the microscope. Not only the direct response to the global pandemic, with vaccinations and treatments, but also the importance of mental health, the care home profe…
The importance of R programming in clinical trials is getting upturned day by day. R can be an ideal platform for measurable investigation and data perception. To biostatisticians and programmers in the pharmaceutical and biotech industry, it offers a wide and rapidly growing range of user-created packages containing capacities that can proficiently control complex data sets and create tables, figures, and postings.
These days, an immense measure of information is gathered during any clinical trial and it is basic for pharmaceutical sponsors to comprehend this information in extraordinary detail to settle on precise choices. Analysts and programmers invest a lot of energy examining data and creating reports for clinical trials, both for conclusive trial reports and break data monitoring adv…
Innovation continues to aid pharmaceutical manufacturers to secure supply chains and protect against counterfeit medicines in the post Brexit landscape, says Dr Paul Dunn, chair of the global trade body International Hologram Manufacturers Association (IHMA).
Innovation continues to aid pharmaceutical manufacturers to secure supply chains and protect against counterfeit medicines in the post Brexit landscape, says Dr Paul Dunn, chair of the global trade body International Hologram Manufacturers Association (IHMA). Trade in counterfeit medicines is one of the largest fraud markets in the world, worth in excess of $200bn per year. It spans organised large-scale trafficking of fake drugs by criminal gangs to small traffickers pursuing illicit sales at a local level. The Covid 19 crisis is…
The digital health revolution continues to reshape the Pharma industry, creating new ways to engage patients, advance development, and create greater adherence.
Digital health has revolutionized nearly every aspect of health care, including the future of pharma. The pharmaceutical industry is embracing digital health tools, in a variety of aspects, to advance how patients take medications and deliver new support resources. Looking toward the future of digital health and pharma integration, innovating the patient experience from clinical trials to adherence to tracking outcomes are central to what lies ahead for the industry. Advancing the drug development process Pharma is incorporating the use of digital health to remodel its approach to clinical trials. With the start of the pandemic, p…
Based on the type of study designs and manuscripts, there are different types of manuscript authoring guidelines such as CONsolidated Standards Of Reporting Trials (CONSORT) for randomized trials; STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) for observational trials; CAse REport guidelines (CARE) for case reports; Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) for systematic reviews and meta-analyses; and STAndards for Reporting of Diagnostic accuracy studies (STARD) for diagnostic accurateness.
Medical Writers often seek information on global best practices that will enhance scientific manuscript writing skills while adhering to industry standards. Here we provide contemporary guidelines that should be followed while publishing…
Over the course of the UK lockdown, manufacturing sectors such as pharmaceutical reaped the benefits in terms of growth. But keeping up with demand is never easy, especially amidst a global pandemic when speed of production became an ever-growing sticking point to meet the needs of scientific discovery. Having been thrust into a digital-first world, businesses in these industries have had no choice but to adapt to survive. Here, Brian Imrie, managing director of adi Facilities Engineering, evaluates how technology has played a key role within the pharmaceutical maintenance strategy, and what changes are set to make a successful stay into the future.
2020 thrust digitisation into the stratosphere across nearly every industry to speak of. With remote working and social distancing negatin…
Companies in the pharmaceutical industry have reached a turning point with business intelligence (BI) technology.
Companies in the pharmaceutical industry have reached a turning point with business intelligence (BI) technology. The data-rich pharmaceutical industry today is not only tasked with solving critical and complex problems to determine brand success but also how company commercial activities eventually affect patient health and economic outcomes. For this, they need data analysis tools that provide them with vital insights, such as how their activity impacts patient health, where the most lucrative opportunities are, and whether trends indicate market shifts. Unfortunately, even after investing millions of dollars into generic BI tools, companies find that they aren’t up to the ta…
First Responders may not be direct partners in the pharmaceutical supply chain, but they are equally responsible for the safety and security of drugs. There are ways to identify that the first responder is using the drugs legally and correctly. From T3 transactions to tracking first responders or dispensers, this article explores the exit point of the supply chain in details.
A lot is known and understood about the operations of a drug supply chain in the United States, which is transforming to cope with the ever-changing requirements of the DSCSA and the drug industry in the country. While everything that the DSCSA says and the participants do root in eliminating the counterfeit drug marketing in the US, compliance standards have evolved into something more prolific than just maintaining p…
Is there a chance that COVID-19 could lead to bankruptcies for life science companies due to supply chain issues? There are a few key points.
The COVID-19 pandemic has impacted everyone and as healthcare organizations and life sciences companies scramble to try to make a vaccine against this deadly virus, there is a growing concern that the COVID-19 pandemic is going to place an undue amount of stress on companies in this sector. Similar to other industries, these businesses have had to adapt their products and services to not only aid in the response to the COVID-19 pandemic but also to meet the growing demand for their services. As they try to maintain shareholder value and navigate numerous regulatory hurdles that are related to the COVID-19 pandemic, there is a growing concern that th…
Data-sharing is crucial for any supply chain activity. But for drug manufacturing and the pharmaceutical sector, it has to be top-notch because the process is multi-layered and complicated. Considering the DSCSA guidance with the aim to combat circulation of counterfeit medicines, information-sharing in this particular sector should not just be streamlined but also be fast and secured. While error-free serialization is a pre-requisite for pharmaceutical track and trace under DSCSA compliance norms, the information in the form of data encryption is a mandate to increase the efficiency and security of the pharmaceutical supply chain.
Pharmaceutical Track and Trace: Sharing the Right Data for a Competent Supply Chain Management Data-sharing is crucial for any supply chain activity. But for dr…
Coronavirus (CoV) is a large family of viruses that cause mild-to-severe illnesses, with common symptoms, such as cough and cold. The severe forms include Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS-CoV). The novel CoV (nCoV) is a new strain of virus that hadn’t been previously detected in humans. These viruses are zoonotic in nature, which means they are transmitted between animals and human patients.
The first outbreak of COVID-19 was detected in Wuhan, Hubei province, China, with an epidemiological link to the Huanan Seafood Wholesale Market, where sale of live animals is conducted. After China's National Health Commission submitted reports, regarding the health condition of people and onset of the novel viral infection, to the World Health Or…
Here are the top Pharma and Life Science recruitment organisations advertising in September on PharmiWeb.jobs.
Barrington James Clinical - 206 Jobs RBW Consulting - 163 Jobs i-Pharm Consulting - 141 Jobs CHASE - 133 Jobs SEC Recruitment - 116 Jobs ID Search & Selection - 86 Jobs Clinical Professionals Ltd - 85 Jobs Hobson Prior - 76 Jobs CK Clinical - 68 Jobs Barrington James Europe - 63 Jobs X4 Life Sciences - 63 Jobs Advanced Regulatory (UK & Europe) - 60 Jobs Barrington James Medical / Executive - 58 Jobs Thornshaw Recruitment - 56 Jobs Barrington James Scientific - 48 Jobs Only Medics Recruitment ltd - 46 Jobs Planet Pharma Staffing Limited - 45 Jobs Umbilical Life - 44 Jobs ProClinical Ltd - 39 Jobs CTC Resourcing Solutions - 34 Jobs Volt - 31 Jobs Haybury - 31 Jobs Advanced S…
A list of the TOP Pharma Companies who are hiring this month (September)
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs   Register and Upload Your CV Now
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products.
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products. Before any biopharmaceutical product goes in to market, it has to get marketing authorization from the relevant health authorities. Market authorization is issued on the basis of an assessment of submitted information that describes the quality, safety and efficacy of the product for a specified indication. Applicants and manufacturers often implement changes in the product, production process, quality controls, equipment, facilities, responsible personnel, or labeling estab…
Herald Meetings brings forth International Conference on Nanotechnology and Nanomaterials the one which is going to takes place at most historic place in Europe Rome, Italy on March 02-03, 2020 brings together leading experts, scientists, researchers, engineers and policymakers in the field of Nanotechnology to Exchange information on the latest innovation and progress. Where you can Connect| Learn| Collaborate
Conference Brochure | Submit Abstract | Scientific Sessions   Herald Meetings takes pleasure in inviting the scientific community across the globe to attend the International Conference on Nanotechnology and Nanomaterials during March 02-03, 2020 at Rome, Italy around the theme "Inquisition of Nanotechnology for better prospective"   Why to Attend?? Nanotechnology 2020 Conf…